super responders to tirzepatide Everyone wants be a responder to the GLP1s, most people are not. Super are more sensitive to GLP1 medications often at lower doses and lose more weight than average Tirzepatide vs. Semaglutide for Weight

doi: 10.1056/NEJMoa042167 11

Starting July 1, eligible Medicare patients can work with their healthcare professional to access our FDA-approved obesity medicine for a $50 monthly copay through the Medicare GLP-1 Bridge

Its key role is to neutralise free radicals the harmful waste products of metabolism that can damage your cells and cause disease and premature ageing

Full maintenance at 2.4 mg requires just 24 units, a tiny injection volume

Advantages include established relationship and familiarity with your medical history, coordination with your overall healthcare, ability to manage routine prescriptions and monitoring, and often shorter wait times than specialists